Speakers Bureau

Faculty willing to give educational talks in Boston and surrounding communities about prevention, brain health, warning signs for Alzheimer’s disease and opportunities for clinical trials.

Cynthia A. Lemere, Ph.D.

Scientist, Ann Romney Center for Neurologic Diseases, Brigham & Women's Hospital
Associate Professor of Neurology, Harvard Medical School

Dr. Lemere focuses on translational research for understanding, preventing and treating Alzheimer's disease. Dr. Lemere earned a bachelor’s degree in Psychology and Education from Mount Holyoke College and a master’s in Neurobiology from SUNY Albany. Dr. Lemere examined Alzheimer's-related brain changes in people with Down syndrome in the Selkoe Laboratory at Brigham and Women's Hospital while pursuing her doctorate in Pathology at Boston University School of Medicine. After receiving her Ph.D., she remained at the Center as a Postdoctoral Research Fellow, Instructor, Assistant Professor and is currently an Associate Professor in the Department of Neurology. Her current research involves: a) preclinical studies of antibody-treatments and vaccines, with and without focused ultrasound treatments, to reduce a disease-relevant form of the amyloid-beta protein that accumulates and forms plaques in the Alzheimer’s brain; b) the role of the body’s immune host-defense system (e.g., complement) in Alzheimer’s disease progression; and, c) the effects of deep space galactic cosmic radiation on brain aging and the risk of Alzheimer’s in preparation for NASA’s first manned mission to Mars in the 2030s. Dr. Lemere participates in local and national mentoring programs for underrepresented minorities including high school, undergraduate and medical students. Dr. Lemere serves on several national and international scientific advisory boards, including the National Alzheimer’s Association Medical and Scientific Advisory Council, the Dominantly Inherited Alzheimer’s Network Therapeutic Unit (DIAN-TU) Therapeutic Evaluation Committee, the International Alzheimer’s Disease/Parkinson’s Disease (ADPD) Conference Scientific Advisory Council, the BrightFocus Foundation Scientific Review Council and the DownSyndrome Achieves Biobank Governing Board of Directors. In addition, she serves as a scientific advisor for several companies

Gad A. Marshall. M.D.

Associate Medical Director of Clinical Trials, Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Massachusetts General Hospital
Assistant Professor of Neurology, Harvard Medical School

Gad Marshall is board certified in Neurology. He is currently the Associate Medical Director of Clinical Trials at the Center for Alzheimer Research and Treatment at Brigham and Women’s Hospital; Associate Neurologist at Brigham and Women’s Hospital; Assistant in Neurology at Massachusetts General Hospital; and Assistant Professor of Neurology at Harvard Medical School. Dr. Marshall has been site principal investigator for multiple clinical trials of amyloid-modifying drugs in Alzheimer’s disease and is currently the site principal investigator for the Alzheimer’s Disease Neuroimaging Initiative (ADNI) 3, DoD-ADNI, and the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) trial. His research has focused on clinical correlates of activities of daily living and neuropsychiatric symptoms with multiple imaging markers and cerebrospinal fluid biomarkers across the early Alzheimer’s disease spectrum, as well as developing novel, sensitive, and ecologically-valid assessments for early functional changes in Alzheimer's disease.

Scott McGinnis, M.D.

Assistant Professor of Neurology, Harvard Medical School

Scott McGinnis is a a behavioral neurologist at the BWH Center for Brain Mind Medicine, an investigator in the BWH Center for Alzheimer Research and Treatment and an investigator in the MGH Frontotemporal Disorders Unit. He completed his residency in neurology in the MGH/BWH program and a fellowship in behavioral neurology and neuropsychiatry at BWH. Dr. McGinnis’ career comprises patient care, education of students, residents, and fellows, and clinical research studies on aging and neurodegenerative dementias. His research interests include atypical presentations of Alzheimer disease and non-Alzheimer cognitive neurodegenerative disorders.

Kathryn V. Papp, Ph.D.

Neuropsychologist, Department of Neurology, Brigham and Women's Hospital 
Research Staff, Department of Neurology, Massachusetts General Hospital
Assistant Professor, Harvard Medical School

Kathryn Papp, PhD is a clinical neuropsychologist with a primary interest in the early detection of Alzheimer’s disease (AD) using sensitive semantic and associative memory tests as well as computerized measures and digital technologies to identify and track older adults at risk for cognitive decline. She is additionally interested in modifiable lifestyle factors which may mitigate cognitive decline in older adults.

Yakeel T. Quiroz, Ph.D.

Instructor in Psychology (Psychiatry), Harvard Medical School

Additional Languages Spoken: Spanish

Yakeel T. Quiroz is a neuropsychologist and clinical researcher at Massachusetts General Hospital/Harvard Medical School. She completed her Ph.D. training in clinical psychology at Boston University and a postdoctoral fellowship at MGH. With an NIH Director’s Early Independence Award, Dr. Quiroz recently launched her own lab where she seeks to identify and validate biomarkers for early detection of Alzheimer’s disease. She also co-directs the Multicultural Neuropsychology Program at MGH, a service that offers culturally appropriate bilingual neuropsychological testing and interventions to Latino children and adults.

Dorene M. Rentz, PsyD

Associate Professor of Neurology, Harvard Medical School
Departments of Neurology, Brigham and Women's Hospital, Massachusetts General Hospital

Dorene M. Rentz, PsyD, is an Associate Professor of Neurology at Harvard Medical School with dual appointments in the Departments of Neurology at Brigham and Women’s Hospital and Massachusetts General Hospital, Boston, Massachusetts. She completed her degree in clinical psychology/neuropsychology in 1987 and has worked as a clinical neuropsychologist for 30 years. She serves in multiple capacities as the Co-Director of the Center for Alzheimer Research and Treatment; the Director of Neuropsychology of the Massachusetts Alzheimer’s Disease Research Center (MADRC); Director of the Outreach, Recruitment and Education Core and Clinical Core Director of the Harvard Aging Brain Study. Her research interests include early detection of cognitive and behavioral changes in preclinical Alzheimer’s disease using novel cognitive assessments as well as amyloid and tau PET imaging. On an international level, Dorene is involved in designing cognitive outcome measures for secondary prevention trials in AD and is a proponent of validating at-home computerized assessments. 

Jeffrey M. Robbins, LICSW

Clinical Social Worker, Brigham and Women's Hospital, Teaching Associate, Harvard Medical School

Jeffrey Robbins is a licensed clinical social worker in Neurology at Brigham and Women’s Hospital and a Teaching Associate in Neurology at Harvard Medical School. Jeff has spent the last 35 years counseling individuals and families living with Alzheimer’s disease and he has given multiple presentations on issues pertaining to caregivers. In 1998 he co-founded The Eleanor Robbins Community Program: Caring for Each Other; a Volunteer program for students wanting to learn about Alzheimer’s disease through weekly visits with a nursing home resident on a dementia care unit. This program became the template for a non- profit, National Alzheimer’s Buddies (NAB), an initiative involving college students who visit those living with Alzheimer’s. NAB currently has 10 colleges across the country who are participating in this program.

Joel A. Salinas, M.D.

Instructor of Neurology at Harvard Medical School and Massachusetts General Hospital

Additional Languages Spoken: Spanish

Dr. Joel Salinas is an Instructor of Neurology at Harvard Medical School and Massachusetts General Hospital. After studying the intersection of biology and sociology at Cornell University, he completed his medical degree at the University of Miami Miller School of Medicine followed by neurology residency at the Massachusetts General Hospital and Brigham and Women’s Hospital. He subsequently completed a combined research and clinical fellowship in Behavioral Neurology and Neuropsychiatry at Massachusetts General Hospital. He conducts research in social and behavioral epidemiology to understand the complex neurobiological interplay between social relationships and brain health.

Qing-Mei Wang, M.D., Ph.D.

Director, Stroke Biological Recovery Laboratory, Spaulding Rehabilitation Hospital
Physician, Spaulding Rehabilitation Hospital, Massachusetts General Hospital
Assistant Professor, Harvard Medical School

Additional Languages Spoken: Mandarin

Dr. Qing Mei Wang obtained her B.S. at Fudan University in Shanghai (1991), Ph.D. (1998) and M.D. (2004) at the University of Medicine and Dentistry of New Jersey and completed residency training in Physical Medicine and Rehabilitation at Mount Sinai Medical Center in New York (2008). She is currently an assistant professor at Harvard Medical School, attending physician at Spaulding Rehabilitation Hospital (SRH), associate physician at Massachusetts General Hospital (MGH), and director of Stroke Biological Recovery Laboratory at Spaulding Rehabilitation Hospital. She provides inpatient/outpatient clinical care, supervises trainees, and conducts research on stroke recovery to enhance our knowledge and the quality of patient care. Dr. Wang’s research involves cellular, animal and clinical disciplines, aiming to bridge basic science breakthrough to bedside therapy, including genetic study, pharmacological intervention and non-invasive brain stimulation to promote stroke recovery. She is also active in community services reaching out to the Chinese population.

Victoria J. Williams, Ph.D.

Clinical Research Fellow in Neurology, Massachusetts General Hospital, Harvard Medical School
Licensed Neuropsychologist

Victoria Williams is a clinical research fellow within the Department of Neurology at Massachusetts General Hospital in affiliation with Harvard Medical School. She completed a B.S. in Psychology at the University of Texas at Austin, followed by a Ph.D. in Clinical Psychology at the University of Houston, specializing in neuropsychology. Following her graduate work, she trained as an intern at the University of California at San Diego, and completed 2 years as a clinical research postdoctoral fellow in neuropsychology within the Boston VA Hospital. She Is currently a research-oriented postdoctoral fellow within the Interdisciplinary Brain Center, and is a licensed Psychologist in the commonwealth of Massachusetts.

Dr. Williams’ research leverages her training and expertise in both clinical neuropsychology and advanced magnetic resonance imaging (MRI) techniques to explore brain-behavior relations in aging and neurodegenerative disease. Her current line of work examines the role of modifiable systemic risk factors (such as cerebrovascular health and physical fitness) in age-related cognitive and neural decline, as well as in dementia onset and progression. Through her involvement within the Interdisciplinary Brain Center, she additionally collaborates with a strong transdisciplinary team whose work focuses on biofluid biomarker discovery in Alzheimer’s Disease and related dementias.

Pages